Crocs (CROX) Earnings Analysis
Crocs (CROX) next reports earnings on 2026-07-30, consensus EPS 4.3 USD. Last quarter (2026-04-30) it beat with EPS 2.99 USD vs 2.78 USD est (+7.6%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -103.97.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CROX next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 4.3 USD |
| Revenue estimate | 1.15B |
CROX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 2.99 USD | 2.78 USD | +7.6% | Beat |
| 2026-02-12 | 2.29 USD | 1.92 USD | +19.3% | Beat |
| 2025-10-30 | 2.92 USD | 2.36 USD | +23.7% | Beat |
| 2025-08-07 | 4.23 USD | 4.01 USD | +5.5% | Beat |
| 2025-02-13 | 2.52 USD | 2.27 USD | +11% | Beat |
| 2024-08-01 | 4.01 USD | 3.56 USD | +12.6% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
CROX valuation and analyst view
| Trailing P/E | -103.97 |
|---|---|
| Trailing EPS | -2.06326 USD |
| Price / book | 4.80 |
| Dividend yield | 0.00% |
| Market cap | 6.75B |
| Analyst consensus | Buy (19 buy / 15 hold / 3 sell) |
| Avg price target | 136 USD |
Related research pages
Frequently asked questions
When is Crocs (CROX)'s next earnings date?
Crocs is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 4.3 USD and revenue estimate of 1.15B.
Did CROX beat earnings last quarter?
In its 2026-04-30 report, CROX posted EPS of 2.99 USD versus a 2.78 USD estimate — a beat of 7.6%.
What is CROX's earnings track record?
Over the last 6 reported quarters with consensus data, CROX beat estimates 6 times (100%).
What is CROX's current P/E ratio and EPS?
CROX trades at a trailing P/E of -103.97 on trailing EPS of -2.063263195576946 USD.
What do analysts rate CROX?
Analyst consensus is "Buy" across 37 ratings (0 strong buy, 19 buy, 15 hold, 3 sell, 0 strong sell). Average 12-month price target: 136 USD.